GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small ...
A teenage patient has become the first in the UK, a hospital said, to receive what medics call a ground-breaking new drug for ...
Results showed that people craved and drank less alcohol when on the drug, according to the findings of a recent study.
Semaglutide, a medication widely used for diabetes and weight loss, may offer another unexpected benefit -- it could help ...
Ozempic is synonymous with weight loss for many people. Doctors explain benefits and risks of semaglutide and other GLP-1 ...
Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with ...
People with type 2 diabetes who take GLP-1 and SGLT-2 medications have a lower risk of having COPD symptom flare-ups than ...
President Donald Trump lamented the cost of a diabetes medication that some Americans are taking for weight loss, or as the ...
Discover how modern diabetes medications offer cardiovascular benefits, transforming diabetes care and improving outcomes worldwide.
The results, published in The Lancet Diabetes and Endocrinology, showed that people in the sotagliflozin group had a 23 per ...
Study led by Mount Sinai researcher shows sotagliflozin is the only drug in its class to demonstrate these results ...
Dr Joyce Huang will be joined by Dr Emma Mead to discuss the ways we’re widening the search for new dementia treatments.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results